Stock Market News

1 month Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive Zacks

Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive have been highlighted in this Screen of The Week article.

Pharmaceuticals · Synchrony Financial (SYF)

9 hours Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks

12 hours Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

2 days Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

2 days Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha

2 days Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks

2 days Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha

2 days Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

4 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance

4 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance

4 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily

5 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com

5 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance

5 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha

5 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

5 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube

5 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks

6 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube

6 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily

7 days Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha

7 days REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks

7 days Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

7 days Here’s Why Synchrony (SYF) is a Strong Value Stock Zacks

7 days Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks

7 days SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks

7 days Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com

1 week Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

1 week 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

1 week Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

1 week Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

1 week Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

1 week Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

2 weeks Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

2 weeks Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

2 weeks Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

2 weeks Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

2 weeks Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

2 weeks How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

2 weeks Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

2 weeks Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

2 weeks Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

2 weeks Here’s Why Synchrony (SYF) is a Strong Momentum Stock Zacks

2 weeks Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks

2 weeks Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks

2 weeks The Zacks Analyst Blog Highlights Deckers Outdoor, Synchrony Financial and Brookfield Asset Management Zacks

2 weeks BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha

2 weeks Synchrony Financial Shares Near 52-Week High: How to Play the Stock? Zacks

2 weeks Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.